CLINICAL RADIOLOGY, vol.74, no.10, pp.797-804, 2019 (SCI-Expanded)
AIM: To evaluate the diagnostic performance of chemical shift magnetic resonance imaging (MRI) in distinguishing hepatocellular carcinomas (HCCs) from non-hepatocellular malignant tumours (non-HCCs) of the liver.